Authors
Latest:
Pharmaceutical Executive Presents The Most Favored Nation MandateJoin us for this premium webinar on September 10!
Latest:
ESG: Applying Lessons From Consumer MarketA prime opportunity for pharma to raise its strategic game in ESG.
Latest:
Supply Chain Analytics: Pharma’s Next Big BetExamining a new three-part formula to enable the supply chain function to manage market pressures while delivering on the bottom line.
Latest:
Supply Chain Analytics: Pharma’s Next Big BetExamining a new three-part formula to enable the supply chain function to manage market pressures while delivering on the bottom line.
Latest:
Beyond the Blame Game: How Pharma is Learning to CollaborateIn a follow-up to our November CEO profile, Novo Nordisk’s Jesper Høiland writes how pharma companies and insurers are learning to collaborate.
Latest:
Marketing: Beware the Hidden Forces of Behavioral EconomicsBrand success can hinge on discovering the deeper motivations of customers and addressing the cognitive biases that result.
Latest:
FDA’s Breakthrough Therapy DesignationThree key questions dominate the agency’s Breakthrough Therapy Designation program since its 2012 launch.
Latest:
Nine Pharma Lessons from the BattlefieldRick Lynch, the Army General who led the Iraqi ‘surge’ campaign, cites nine lessons that pharma leaders can apply in today’s come-from-behind struggle for market share.
Latest:
Withdrawal of EU Investigation of the Patent Box: Good News for UK InnovatorsThe European Commission’s (EC) decision to withdraw its investigation into the UK Government's Patent Box scheme is positive news for British innovators, writes Michael Jaeger.
Latest:
The End of Pharma Marketing— or a New Beginning?Two commercial marketing experts discuss how this mission critical function must change to stay relevant in bringing new therapies to the patients who need them.
Latest:
Case Study: A Drug Launch into COVID HeadwindsLessons to launch by during a pandemic—or otherwise.
Latest:
Philanthropy vs. Innovation - Current Vaccine Prices: Is There a Downside?Amid COVID-19, pressure for “socially responsible” pricing could temper investments in future urgent healthcare needs.
Latest:
Pharma Boards in the Era of Hostile TakeoversWith hostile takeovers on the rise, Mike Straw argues that pharma boards have a huge role to play in managing the people issues.
Latest:
Prastera: A Drug Listing Submission Case StudyMark Gross offers a case study in using structured product labeling (SPL) to reduce time to market.
Latest:
Pharma's Love Affair with BuzzwordsHow pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality, by Lundbeck's Timothy White.
Latest:
Tomorrow’s Selling Strategies: Invest & TestA new PwC survey reveals a strong need to fully embrace alternative commercial methods-not in a blind frenzy but through careful evaluation of which new sales strategies have true innovative potential.
Latest:
Value-Based Planning Uncovers True Drivers of Cost Across Life Sciences OrganizationsExplicitly tying strategic planning to resource allocation boosts bottom-line productivity for pharma.
Latest:
Tomorrow’s Selling Strategies: Invest & TestA new PwC survey reveals a strong need to fully embrace alternative commercial methods-not in a blind frenzy but through careful evaluation of which new sales strategies have true innovative potential.
Latest:
Refuting R&D Tax Credit MythsWhy executives should make the US R&D tax credit part of their planning discussions, by Chai Hoang and Chris Bard.
Latest:
So What is Pharma’s Ideal Role in Social?Advertorial: Ashfield Commercial & Medical Services believes that Pharma can use social media to play an important role in educating the healthcare professional (HCP) and the patient
Latest:
Patients, Physicians, and Payers… How Can Pharma Do it All?The word ‘centric’ by definition means one, as in focused on a single entity. Yet, in today’s life sciences industry, companies are customer-centric and patient-centric and physician-centric - combined. It's counterintuitive…if not overwhelming, writes Lisa Barbadora
Latest:
Personalized Medicine at a CrossroadsPersonalized medicine has reached a crossroads where fundamental change is not only appealing but essential, write Klarissa Hoday, Francesca Boggio, and Aleksander Ruzicic.
Latest:
Patients' Role in Healthcare Decisions Will Transform Industry’s Model of CareDavid Logue sees the industry adapting to address medical needs and deliver treatments to patients in ways that afford greater personal empowerment.
